Drug Information

Drug General Information
Drug ID
D0S5OR
Former ID
DNC014195
Drug Name
(+/-)-Daedalin A
Drug Type
Small molecular drug
Indication Discovery agent Investigative [530600]
Formula
C11H12O3
Canonical SMILES
CC1(C=CC2=C(O1)C=CC(=C2)O)CO
InChI
1S/C11H12O3/c1-11(7-12)5-4-8-6-9(13)2-3-10(8)14-11/h2-6,12-13H,7H2,1H3/t11-/m1/s1
InChIKey
LTKJWSBGTNWRNP-LLVKDONJSA-N
PubChem Compound ID
46230831
Target and Pathway
Target(s) Tyrosine oxidase Target Info Inhibitor [530600]
BioCyc Pathway (S)-reticuline biosynthesis
Eumelanin biosynthesis
L-dopachrome biosynthesis
KEGG Pathway Tyrosine metabolism
Riboflavin metabolism
Metabolic pathways
Melanogenesis
PathWhiz Pathway Riboflavin Metabolism
Tyrosine Metabolism
WikiPathways Dopamine metabolism
References
Ref 530600Bioorg Med Chem Lett. 2010 Feb 1;20(3):1063-4. Epub 2009 Dec 11.Asymmetric syntheses of daedalin A and quercinol and their tyrosinase inhibitory activity.
Ref 530600Bioorg Med Chem Lett. 2010 Feb 1;20(3):1063-4. Epub 2009 Dec 11.Asymmetric syntheses of daedalin A and quercinol and their tyrosinase inhibitory activity.

If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Tang and Dr. Zhang.